Tekla Life Sciences Investors
Status: Publicly traded
Direct answer
Tekla Life Sciences Investors is publicly traded on NYSE under the ticker HQL.
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a diverse range of...
Can you invest in Tekla Life Sciences Investors?
Yes. Tekla Life Sciences Investors is publicly traded on NYSE under the ticker HQL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Tekla Life Sciences Investors
Detailed equity research is provided by MarketSnap.